| News

Startup Academy celebrates anniversary

25.06.2020

Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.

Networking event of Startup Academy (img: Startup Academy)

Startup Academy was created in Basel in June 2010. The initiative’s aim is to connect people with business ideas together with experts from the economy. Additionally, Startup Academy supports startups with a two-year program, in which it helps the companies to successfully master the first few years. This model is working: Nine out of ten startups completing the program go on to survive.

According to a press release, Startup Academy has already supported 280 startups so far, creating 706 jobs in the process. OMNI Life Science GmbH is one of the startups that received guidance. Britta Gerlach, CEO of the startup from Basel, says: “For me, the most valuable part was the contact with the mentor, who always supported us, even with building up a network.”

The initiative was originally started in Basel but is now already known across Switzerland. In addition to its hometown, there are also locations in Bern, La Côte VD, Liestal, Olten SO and Zurich. At this point in time, 89 startups are being supported at these locations. Two additional locations are planned for the canton of Graubünden and the canton of Ticino.

To celebrate its anniversary, Startup Academy is giving credit of 240 Swiss francs to every startup that is newly admitted to the support program in 2020. It is also organizing a network event in Basel on the occasion of the anniversary on November 10th.

Startup Academy is a non-profit organization. It is currently supported by Engagement Migros. Basel Area Business & Innovation is a network partner of the Startup Academy location Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest

Basel is “probably the most productive life sciences location in the world”

Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area cantons publish joint economic report

The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described as “good” in the report.

Read More
Basel Area Business & Innovation, Innovation

Resistell receives high-level EU grant

Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.

Read More
Basel Area Business & Innovation, Innovation

Artidis ends successful study

Artidis, a startup from Basel, has developed a nanotechnology platform that can be used for cancer diagnosis, among other things. The platform has now been tested in a study that was able to achieve its primary endpoint.

Read More
Basel Area Business & Innovation, Innovation

Startup Academy celebrates anniversary

Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.

Read More
Basel Area Business & Innovation, Innovation

Tolremo raises additional funding

The Muttenz-based biotechnology company Tolremo Therapeutics has raised an additional 4.7 million Swiss francs as part of a financing round. The company develops cancer therapies for precision medicine and is now driving forward clinical development.

Read More
1 2 3 20

Do you have a question? We'd like to hear from you.